Atropine sulphate (Ocumension Therapeutics)

硫酸阿托品 (欧康维视生物医药（上海）有限公司)

Report date: 2025/05/15 20:00:08

Base Information

Drug NameAtropine sulphate (Ocumension Therapeutics)
Drug Alias NameAtropine Sulfate 0.01% (Ocumension Therapeutics)OT-101 (Ocumension Therapeutics)OT-101-SOT-101S
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsMyopia, DegenerativeMyopia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSlovakiaNetherlands +[7] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesOcumension Therapeutics (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLyophilization Technology IncOcumension (Hong Kong) LtdOcumension Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsMyopia, DegenerativeMyopia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A